Clicks Group Limited (CLS.JO) stock analysis
In our weekly check, Clicks Group Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 5, red flags: 3.
About Clicks Group Limited
Clicks Group Limited is a Healthcare company (Medical - Pharmaceuticals) based in South Africa, listed on JNB as CLS.JO.
What our checks show for CLS.JO
Red flags
- Operating profit does not cover the interest bill (0.7x): interest is paid from cash or new debt.
- The dividend takes 1067% of profit: little cushion if profit falls.
- A small company (market value $29 million): usually riskier and followed by fewer analysts.
Warning signs
- The net margin fell by 0.6 points over 5 years, to 6.1%: the company keeps less of each sale as profit.
- Analysts expect only about 3.8% a year of growth in revenue.
- The net margin is only 6.1%: little room if costs rise.
- The stock has fallen as much as 54% from a peak. Would you have held through that?
- The stock is still below its previous peak.
Strengths
- The gross margin is 25.1% and has risen by 3.8 points: pricing power is holding.
- Operating cash flow is 1.45x net profit: the profit arrives as real cash.
- Earnings per share grew 10.9% a year over the last 3 years.
- Beta 0.12: the stock usually moves less than the market.
- Return on capital (ROCE) is 48.8%: the business earns well on the money put into it.
- Pay in shares is only 0% of free cash flow.
Similar companies
RPRX · 1177.HK · RADL3.SA · 6618.HK · SOBI.ST · REC.MI
Questions
What grade does Clicks Group Limited (CLS.JO) have?
In our weekly check, Clicks Group Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 5, red flags: 3. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of CLS.JO stock?
This week's biggest flags for Clicks Group Limited: Weak interest cover, Dividend stretched, Small company. In total 8 of 25 checks show a warning or a red flag.
What does Clicks Group Limited do?
Clicks Group Limited is a Healthcare company (Medical - Pharmaceuticals) based in South Africa, listed on JNB as CLS.JO.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-10-31
Open the full analysis